Roderick Blair, a resident of the Homewood neighborhood in Pittsburgh, was surprised when scientific researchers appeared at his doorstep on a recent summer day. The scene in Homewood was stark: police cars, an ambulance, and a TV reporter crowded into a driveway; a helicopter swung overhead. The neighborhood showed signs of disrepair, with broken windows, boarded doors, and overgrown lots.
Blair was part of a study that has now been cancelled. According to a report by The Guardian, participants in Pittsburgh may never learn the results of their cognitive tests because funding cuts that target DEI have the potential to cause significant delays in diagnosis. The cancellation has been described as an act of retribution, with the federal government withdrawing support from research that focuses on underserved populations.
The study was seen as critical for understanding Alzheimer's disease in communities that have historically been underrepresented in medical research. Without the results, individuals like Blair may lose access to early intervention and treatment options that could improve their quality of life. The broader implications extend to public health, as the loss of this research could slow progress in addressing disparities in Alzheimer's care.